Acute Decompensated Heart Failure Clinical Trials
2 recruiting trials for Acute Decompensated Heart Failure. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Acute Decompensated Heart Failure clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by University of Oklahoma (1), University Hospital, Basel, Switzerland (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Neuromodulation (device, 1 trial), followed by no internvention.
Track Acute Decompensated Heart Failure trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Low Level Tragus Stimulation in Acute Decompensated Heart Failure
Acute Decompensated Heart Failure (ADHF) is a major cause of morbidity and mortality. It is associated with increased systemic inflammation. Previous studies have demonstrated...
BEAT-SHOCK Registry
This regulation defines the purpose, the operational processes, and the organization of the registry BEAT-SHOCK (Basel Evaluation of Acute Therapy in cardiogenic SHOCK). It...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Acute Decompensated Heart Failure, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Acute Decompensated Heart Failure, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Acute Decompensated Heart Failure, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.